Angiotech Pharmaceuticals, Inc. (ANPI, ANP.TO) reported third quarter net loss of US$7.8 million or US$0.09 per share, compared to net loss of US$622.38 million or US$7.31 per share last year. The company noted that the prior year results were restated.
Adjusted net income was US$0.1 million or breakeven per share for the quarter.
Revenue declined to US$63.24 million from US$68.36 million in the same quarter last year.
For comments and feedback: editorial@rttnews.com